Long COVID: What Have We Learned So Far?
![](https://stlcovidresearchhub.wustl.edu/files/2024/02/WhatWeKNowFront-38724af214478e0a-350x453.png)
Researchers led by Dr. Eric Lenze, director of the Healthy Mind Lab at Washington University School of Medicine, are running a clinical trial of the drug fluvoxamine. They hope fluvoxamine will help those struggling with Long COVID brain fog, memory, attention, and concentration problems. “We think fluvoxamine may help many patients suffering from long COVID’s […]